Research programme: fibroblast growth factor-2 - Buck Institute/Neurobiological Technologies
Alternative Names: FGF-2 - Buck Institute/Neurobiological Technologies; Huntington's disease programme - Buck Institute/Neurobiological TechnologiesLatest Information Update: 22 May 2009
At a glance
- Originator Buck Institute for Age Research; Neurobiological Technologies
- Class Fibroblast growth factors
- Mechanism of Action Fibroblast growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Huntington's disease
Most Recent Events
- 22 May 2009 Discontinued - Preclinical for Huntington's disease in USA (Parenteral)
- 03 Dec 2007 Preclinical trials in Huntington's disease in USA (Parenteral)